Quick Order Cart

Cat. No. ARG0695

WAS Knockout Ramos Cell Line

  • Product Type:

    Genome-edited Cells

  • Tissue Source:

    Ascites

  • Disease:

    Burkitt lymphoma

  • Gene Species:

    Homo sapiens (Human)

The WAS Knockout Ramos Cell Line is a CRISPR/Cas9-edited knockout human B lymphocyte line targeting WAS, the gene encoding WASP. Disruption of WASP impairs actin polymerization, B cell receptor signaling, and immune synapse formation. WASP acts downstream of CDC42 and partners with WIP and NCK to activate the ARP2/3 complex; its loss models Wiskott-Aldrich syndrome and X-linked thrombocytopenia. This cell line supports investigations into actin dynamics, B cell signaling, and immune dysregulation. Compatible with flow cytometry, actin polymerization assays, and phospho-signaling readouts, it enables detailed mechanistic studies in immunology and cancer biology.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    Ramos

    Morphology

    Lymphocyte-like

    Age

    3 years

    Sex of Donor

    Male

    Gene Name

    WAS

    Gene Species

    Homo sapiens (Human)

    Gene Identifier

    NCBI Gene ID 7454

  • Culture Conditions

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

    Pathogens

    Cells tested negative for HIV-1, HBV, and HCV.

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The WAS Knockout Ramos Cell Line is a CRISPR/Cas9-edited knockout cell line derived from the human Ramos B lymphocyte line, engineered to disrupt the WAS gene. This loss-of-function model allows rigorous investigation of WASP-dependent actin polymerization and its roles in immune cell signaling, particularly B cell receptor (BCR) signaling, immune synapse formation, and lymphocyte motility. It provides a genetically defined tool for exploring WAS deficiency in a malignant B cell context.

The parental Ramos cell line is a Burkitt??s lymphoma-derived B lymphocyte line that retains key mature B cell features, including robust BCR signaling and antibody production. Its well-characterized signaling networks and genetic tractability make it ideal for knockout studies, enabling direct assessment of how WAS disruption impacts B cell responses and lymphomagenesis.

The WAS gene encodes WASP, a hematopoietic-specific actin nucleation-promoting factor that integrates upstream signals to control ARP2/3 complex-mediated actin polymerization. WASP is activated by CDC42 and PIP2, and its activity is modulated by SRC family kinases and BCR stimulation. Upon activation, WASP recruits and activates the ARP2/3 complex to drive branched actin assembly. Interacting partners such as WIP, NCK, and GRB2 regulate WASP stability and localization. Downstream, WASP-mediated actin dynamics promote filopodia formation and are essential for immune synapse architecture and cell motility.

In Ramos cells, WAS knockout severely impairs actin-dependent BCR signaling processes, including immune synapse formation, downstream kinase signaling, and cell migration. These defects recapitulate features of Wiskott-Aldrich syndrome and X-linked thrombocytopenia, establishing this line as a relevant model for these immunodeficiencies. Moreover, given WASP??s role in autoimmunity and hematologic malignancies, the model supports research into actin regulatory defects in tumor biology and immune dysregulation.

This knockout cell line is suitable for diverse applications, including Western blotting and RT-qPCR for gene disruption verification and pathway component analysis. Flow cytometry permits assessment of signaling readouts, while actin polymerization and cell migration assays probe cytoskeletal dynamics. Phospho-signaling analysis and immunofluorescence for F-actin facilitate detailed studies of BCR signaling and immune synapse remodeling. These tools collectively enable mechanistic dissection of WASP function in health and disease. For further information or to request a quote, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)